These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 20163849)

  • 21. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
    Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
    Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tagging single nucleotide polymorphisms in phosphoinositide-3-kinase-related protein kinase genes involved in DNA damage "checkpoints" and lung cancer susceptibility.
    Hu Z; Liu H; Wang H; Miao R; Sun W; Jin G; Wang Y; Ma H; Jin L; Wei Q; Lu D; Huang W; Shen H
    Clin Cancer Res; 2008 May; 14(9):2887-91. PubMed ID: 18451257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline genetic polymorphisms of CYP1A1, GSTM1 and GSTT1 genes in Indian cervical cancer: associations with tumor progression, age and human papillomavirus infection.
    Joseph T; Chacko P; Wesley R; Jayaprakash PG; James FV; Pillai MR
    Gynecol Oncol; 2006 Jun; 101(3):411-7. PubMed ID: 16360200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Correlation analysis between miR-124 rs531564 polymorphisms and susceptibility to cervical cancer].
    Xiong X; Cheng J; Liu X; Tang S; Luo X
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):210-3. PubMed ID: 24589598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Common genetic polymorphisms in pre-microRNAs and risk of cervical squamous cell carcinoma.
    Zhou B; Wang K; Wang Y; Xi M; Zhang Z; Song Y; Zhang L
    Mol Carcinog; 2011 Jul; 50(7):499-505. PubMed ID: 21319225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CTLA-4 gene polymorphism +49 A/G contributes to genetic susceptibility to two infection-related cancers-hepatocellular carcinoma and cervical cancer.
    Hu L; Liu J; Chen X; Zhang Y; Liu L; Zhu J; Chen J; Shen H; Qiang F; Hu Z
    Hum Immunol; 2010 Sep; 71(9):888-91. PubMed ID: 20538028
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of immunological genes on chromosome 2q33 and IFNG in susceptibility to cervical cancer.
    Ivansson EL; Juko-Pecirep I; Gyllensten UB
    Gynecol Oncol; 2010 Mar; 116(3):544-8. PubMed ID: 19959217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population.
    Thakur N; Hussain S; Kohaar I; Tabassum R; Nasare V; Tiwari P; Batra S; Bhambhani S; Das BC; Basir SF; Bharadwaj D; Bharadwaj M
    Biomarkers; 2009 Jun; 14(4):219-25. PubMed ID: 19489683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and polimorphism of IFN-gamma gene in patients with cervical cancer.
    Kordi Tamandani MK; Sobti RC; Shekari M; Mukesh M; Suri V
    Exp Oncol; 2008 Sep; 30(3):224-9. PubMed ID: 18806746
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of DNA repair gene XRCC1 and lung cancer susceptibility among nonsmoking Chinese women.
    Yin J; Vogel U; Ma Y; Qi R; Wang H
    Cancer Genet Cytogenet; 2009 Jan; 188(1):26-31. PubMed ID: 19061777
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of methylenetetrahydrofolate reductase polymorphism C677T and dietary folate with the risk of cervical dysplasia.
    Goodman MT; McDuffie K; Hernandez B; Wilkens LR; Bertram CC; Killeen J; Le Marchand L; Selhub J; Murphy S; Donlon TA
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1275-80. PubMed ID: 11751445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck.
    An J; Liu Z; Hu Z; Li G; Wang LE; Sturgis EM; El-Naggar AK; Spitz MR; Wei Q
    Cancer Epidemiol Biomarkers Prev; 2007 Aug; 16(8):1633-8. PubMed ID: 17684138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A variant affecting miRNAs binding in the circadian gene Neuronal PAS domain protein 2 (NPAS2) is not associated with breast cancer risk.
    Wang F; Hu Z; Yang R; Tang J; Liu Y; Hemminki K; Sutter C; Wappenschmidt B; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B; Shen H
    Breast Cancer Res Treat; 2011 Jun; 127(3):769-75. PubMed ID: 21140207
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papillomavirus and p53 polymorphism in Lithuanian cervical cancer patients.
    Gudleviciene Z; Didziapetriene J; Ramael M; Uleckiene S; Valuckas KP
    Gynecol Oncol; 2006 Sep; 102(3):530-3. PubMed ID: 16488468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
    Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
    Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional variant in microRNA-196a2 contributes to the susceptibility of congenital heart disease in a Chinese population.
    Xu J; Hu Z; Xu Z; Gu H; Yi L; Cao H; Chen J; Tian T; Liang J; Lin Y; Qiu W; Ma H; Shen H; Chen Y
    Hum Mutat; 2009 Aug; 30(8):1231-6. PubMed ID: 19514064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
    Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
    Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. REV3L 3'UTR 460 T>C polymorphism in microRNA target sites contributes to lung cancer susceptibility.
    Zhang S; Chen H; Zhao X; Cao J; Tong J; Lu J; Wu W; Shen H; Wei Q; Lu D
    Oncogene; 2013 Jan; 32(2):242-50. PubMed ID: 22349819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.